Prescription Reimportation, Improvement, Correction, and Enhancement Act

The Prescription Reimportation, Improvement, Correction, and Enhancement Act (H.R. 698) was designed to allow pharmacists and wholesalers to import FDA-approved prescription drugs from foreign countries where they are often sold at lower prices. The bill sought to lower medication costs for Americans by requiring imported drugs to meet strict safety, testing, and labeling standards to ensure they are identical to those sold in the United States. Additionally, the legislation included provisions to prevent pharmaceutical manufacturers from using discriminatory pricing or supply tactics to block these imports.